Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04123-y
Abstract: Temozolomide is the most effective chemotherapy for malignant glioma. Hypersensitivity requiring interruption of therapy may significantly impact patient survival. We have successfully employed temozolomide desensitization followed by metronomic dosing of temozolomide. Our purpose was to… read more here.
Keywords: desensitization followed; temozolomide desensitization; metronomic dosing; hypersensitivity ... See more keywords